Table 1.
Comparison of triphasic pattern measurements of EMG activity
| Condition | |||||
|---|---|---|---|---|---|
| Control | TMSCT | SAS | TMSSAS | TMSSAS+SAS | |
| AG1 duration | 90.0 ± 13.9 | 83.5 ± 9.4 | 89.5 ± 11.1 | 88.7 ± 9.4 | 84.5 ± 10.0 |
| ANTAG duration | 109.5 ± 18.1 | 100.9 ± 17.8 | 107.6 ± 22.2 | 107.8 ± 16.9 | 106.7 ± 25.9 |
| AG2 duration | 87.3 ± 12.4 | 79.3 ± 12.0 | 85.8 ± 7.7 | 83.8 ± 11.3 | 81.3 ± 14.4 |
| AG1–ANTAG interval | 51.1 ± 10.6 | 48.3 ± 11.6 | 50.6 ± 7.9 | 47.3 ± 12.1 | 47.4 ± 11.6 |
| AG1–AG2 interval | 128.2 ± 20.5 | 119.4 ± 18.4 | 128.5 ± 18.7 | 127.8 ± 21.4 | 122.1 ± 25.7 |
AG1, first agonist burst (ED); ANTAG, antagonist burst (FCR); AG2, second agonist burst (ED); AG1–ANTAG interval, the time interval between AG1 onset and ANT onset; AG1–AG2, the time interval between AG1 onset and AG2 onset.